VETNOSTRUM ANIMAL HEALTH CO LTD (6936.TW)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in TWDTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | TWD m | - | - | - | - | - | - | - | - |
| Operating profit | TWD m | - | |||||||
| Net profit | TWD m | - | - | - | - | - | - | - | - |
| EPS reported | TWD | - | |||||||
| Operating cashflow per share | TWD | - | |||||||
| Capex per share | TWD | - | |||||||
| FCF per share | TWD | - | |||||||
| Free cash flow | TWD m | - | |||||||
| Net debt | TWD m | - | |||||||
| Book value equity | TWD m | - | |||||||
| Book value per share | TWD | - | |||||||
| Number of shares | m | - | |||||||
| DPS (TTM paid) | TWD | - |
Financial summary
Financials in TWDTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | |||||||
| P/B LTM | x | - | |||||||
| P/S LTM | x | - | |||||||
| P/FCF LTM | x | - | |||||||
| EV/EBITDA LTM | x | - | |||||||
| EV/Sales LTM | x | - | |||||||
| Earnings Yield LTM | % | - | |||||||
| FCF Yield | % | - | |||||||
| Quality | |||||||||
| ROE | % | - | |||||||
| ROIC | % | - | |||||||
| Operating margin | % | - | |||||||
| Gross margin | % | - | |||||||
| FCF/Sales | % | - | |||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | |||||||
| Sales Growth YoY | % | - | |||||||
| Net Income Growth YoY | % | - | |||||||
| FCF Growth | % | - | |||||||
| Operating Profit Growth | % | - | |||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | - | |||||||
| Dividend Growth | % | - | |||||||
| Payout Ratio | % | - | |||||||
| FCF/Debt | x | - | |||||||
| Net Debt/EBITDA | x | - | |||||||
| EBIT/Net interest | x | - | |||||||
| Net debt/market cap | % | - | |||||||
| Net debt/Equity | x | - | |||||||
| Gross debt/equity | x | - | |||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Vetnostrum is a company focused on animal health products, including veterinary medicines, functional feed additives, and nutritional supplements for both livestock and companion animals. As one of Taiwan's leading large-scale veterinary pharmaceutical manufacturers, it leverages human-grade pharmaceutical standards across its R&D and production. The company holds numerous domestic and international product licenses and serves clients like feed mills, livestock farms, and veterinary hospitals, while also developing its own pet brand, Koolpal.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
VETNOSTRUM ANIMAL HEALTH CO LTD (6936.TW)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Vetnostrum is a company focused on animal health products, including veterinary medicines, functional feed additives, and nutritional supplements for both livestock and companion animals. As one of Taiwan's leading large-scale veterinary pharmaceutical manufacturers, it leverages human-grade pharmaceutical standards across its R&D and production. The company holds numerous domestic and international product licenses and serves clients like feed mills, livestock farms, and veterinary hospitals, while also developing its own pet brand, Koolpal.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free